Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Inventory (2021 - 2025)

Oncology Institute (TOI) has disclosed Change in Inventory for 5 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 354.61% year-over-year to $3.1 million, compared with a TTM value of $8.8 million through Sep 2025, up 517.9%, and an annual FY2024 reading of -$3.6 million, down 182.99% over the prior year.
  • Change in Inventory was $3.1 million for Q3 2025 at Oncology Institute, down from $3.5 million in the prior quarter.
  • Across five years, Change in Inventory topped out at $3.5 million in Q2 2025 and bottomed at -$2.1 million in Q1 2024.
  • Average Change in Inventory over 5 years is $692789.5, with a median of $502000.0 recorded in 2021.
  • The sharpest move saw Change in Inventory skyrocketed 13420.0% in 2022, then tumbled 20366.67% in 2024.
  • Year by year, Change in Inventory stood at $502000.0 in 2021, then tumbled by 269.72% to -$852000.0 in 2022, then soared by 272.77% to $1.5 million in 2023, then plummeted by 104.55% to -$67000.0 in 2024, then soared by 4720.9% to $3.1 million in 2025.
  • Business Quant data shows Change in Inventory for TOI at $3.1 million in Q3 2025, $3.5 million in Q2 2025, and $2.3 million in Q1 2025.